Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Butler et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00310-6
https://c19early.org/butler.html